Back to Search
GAURAV BANSAL, D.O.
D.O.
Anesthesiology Physician
NPI: 1427468545IndividualAccepts Medicare
Education
WESTERN UNIVERSITY OF HEALTH SCIENCES COLLEGE OF DENTAL MED
Class of 2014
Research & Publications (20)
RGS16 inhibits breast cancer cell growth by mitigating phosphatidylinositol 3-kinase signaling.
PMID 19509421·J Biol Chem·2009
8-other
RGS13 controls g protein-coupled receptor-evoked responses of human mast cells.
PMID 19017978·J Immunol·2008
7-preclinical
Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists.
PMID 19013821·Bioorg Med Chem·2008
7-preclinical
LC-UV-PDA and LC-MS studies to characterize degradation products of glimepiride.
PMID 18804934·J Pharm Biomed Anal·2008
8-other
LC and LC-MS study on establishment of degradation pathway of glipizide under forced decomposition conditions.
PMID 18647472·J Chromatogr Sci·2008
8-other
Detection of viable Mycobacterium leprae in soil samples: insights into possible sources of transmission of leprosy.
PMID 18599381·Infect Genet Evol·2008
8-other
Mucosal immunity and HIV/AIDS vaccines. Report of an International Workshop, 28-30 October 2007.
PMID 18513838·Vaccine·2008
7-preclinical
Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.
PMID 18158200·Eur J Med Chem·2008
7-preclinical
Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13.
PMID 18026105·Nat Immunol·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1959 NE PACIFIC ST
SEATTLE, WA 98195 - Phone
- (206) 598-3300
Quick Facts
- NPI
- 1427468545
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile